In IP Litigator, MBHB Partner Kevin Noonan provides a detailed analysis of the Federal Circuit’s decision in Agilent Technologies Inc. v. Synthego Corp. Noonan explores the court’s reasoning in affirming the PTAB’s invalidation of CRISPR-Cas9 patents and highlights the enduring impact of the Supreme Court’s decision in Dickinson v. Zurko. Read the article.